Stock data
REGENXBIO Inc. (RGNX)
REGENXBIO Inc. (RGNX) reported revenue of US$170.44M and net income of -US$193.88M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$170.44M | — | -US$161.20M | -US$193.88M | — |
| 2024 | US$83.33M | — | -US$233.35M | -US$227.10M | — |
| 2023 | US$90.24M | — | -US$268.13M | -US$263.49M | — |
| 2022 | US$112.72M | — | -US$262.88M | -US$280.32M | — |
| 2021 | US$470.35M | — | US$159.98M | US$127.84M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$108.02M | US$22.71M | — |
| 2026-03-31 | US$6.39M | -US$90.05M | — |
| 2025-12-31 | US$30.34M | -US$67.15M | — |
| 2025-09-30 | US$29.73M | -US$61.94M | — |
| 2025-06-30 | US$21.36M | -US$70.87M | — |
| 2025-03-31 | US$89.01M | US$6.08M | — |
| 2024-12-31 | US$21.21M | -US$51.19M | — |
| 2024-09-30 | US$24.20M | -US$59.60M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.